ARCHIVES

Afinitor Tablet Doubles PFS; Lowers Progression Risk 65%

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

September 29, 2006

NCAB Oks LANs To Links NCI Staff With Each Other, The World

February 14, 1992

Obey Again – Now He’s Blasting NCI For Not Helping NIOSH

September 17, 1976

CCRAC Shoots Down Two Projects, Approves Others

December 15, 1978

NCI To Pay 34 Percent Of Grants, At 155 Payline; $100 Million for Centers to Fund All Core Grants

January 29, 1988

Flexibility OK In Paying Grants If Justified, Upton Affirms

September 1, 1978